Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics - ScienceDirect
Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment - ScienceDirect
Peripheral Kappa Opioid Receptor Signaling Takes on a Central Role - ScienceDirect
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Structure of the human κ-opioid receptor in complex with JDTic | Nature
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Opioids in cancer: The κ‑opioid receptor (Review)
κ-Opioid Receptor (KOP) | 7TM Antibodies
Dynorphin/kappa-opioid receptor control of dopamine dynamics: Implications for negative affective states and psychiatric disorders - ScienceDirect
The blocking of kappa‐opioid receptor reverses the changes in dorsolateral striatum dopamine dynamics during the amphetamine sensitization - Azocar - 2019 - Journal of Neurochemistry - Wiley Online Library
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Biased ligands at opioid receptors: Current status and future directions | Science Signaling
Kappa opioid receptor (KOR) modulation of dopamine in the cortex and... | Download Scientific Diagram
The Role of Opioids and Their Receptors in Urological Malignancy: A Review
Will peripherally restricted kappa‐opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? - Albert‐Vartanian - 2016 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
Scientists Take a Big Step toward Building a Better Opioid | Newsroom
Kappa Opioid Receptor Structure Revealed, A Potential Milestone in Medication Development | National Institute on Drug Abuse (NIDA)